IDDM is a dynamic process involving the destruction of the pancreatic islet cells by lymphocytes. The process can be appreciated, quantified and characterized visually by histological techniques. The main goal of the histology core is to provide reproducible high quality histochemistry techniques to the investigators in this program project. The principle investigator of the histology core has much experience in the area of pancreatic histology. The core will accept both fixed and frozen tissue from investigators and produce high quality histological sections stained with hematoxylin and eosin. The core will also perform immunocytochemistry studies with antibodies to the pancreatic islet hormones and leukocyte subsets for the investigators in the program. The core director will be available to review slides with the investigators and postdocs involved in the research in this program. The investigators in this program project will provide the workload of the core. When the workload becomes overwhelming, the core direction, in consultation with the program director will prioritize the work schedule as best suits the overall goals of this program project. The core will keep abreast of new techniques and newly available reagents in the histochemistry/immunocytochemistry field, establishing these techniques for use of investigators in the program. The histology core is an important central resource for the investigators in this program project, enabling the dynamic cellular processes that occur in IDDM to be visualized and interpreted.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK057644-03
Application #
6589296
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2002-06-01
Project End
2003-05-31
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
$221,358
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Martinez, Xavier; Kreuwel, Huub T C; Redmond, William L et al. (2005) CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles. J Immunol 175:1677-85
Yadav, Deepak; Judkowski, Valeria; Flodstrom-Tullberg, Malin et al. (2004) B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets. J Immunol 173:3631-9
Redmond, William L; Hernandez, Javier; Sherman, Linda A (2003) Deletion of naive CD8 T cells requires persistent antigen and is not programmed by an initial signal from the tolerogenic APC. J Immunol 171:6349-54
Kreuwel, H T; Biggs, J A; Pilip, I M et al. (2001) Defective CD8+ T cell peripheral tolerance in nonobese diabetic mice. J Immunol 167:1112-7
Pakala, S V; Ilic, A; Chen, L et al. (2001) TNF-alpha receptor 1 (p55) on islets is necessary for the expression of LIGHT on diabetogenic T cells. Clin Immunol 100:198-207
Kreuwel, H T; Sherman, L A (2001) Defects in deletional tolerance of CD8+ T cells in autoimmune diabetes. Curr Dir Autoimmun 4:123-43
Kreuwel, H T; Sherman, L A (2001) The role of Fas-FasL in CD8+ T-cell-mediated insulin-dependent diabetes mellitus (IDDM). J Clin Immunol 21:15-8
Kreuwel, H T; Sherman, L A (2001) The T-cell repertoire available for recognition of self-antigens. Curr Opin Immunol 13:639-43
Murtaza, A; Nugent, C T; Tailor, P et al. (2001) Altered functional and biochemical response by CD8+ T cells that remain after tolerance. Int Immunol 13:1085-93